SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1.71 Cr | ₹1.35 Cr | ₹2.46 Cr | ₹3.58 Cr | ₹4.50 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1.71 Cr |
| Mar2024 | ₹1.35 Cr |
| Mar2023 | ₹2.46 Cr |
| Mar2022 | ₹3.58 Cr |
| Mar2021 | ₹4.50 Cr |
How is Total Non-Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.71 Cr | 27.12 | |
| Mar2024 | ₹1.35 Cr | -45.33 | |
| Mar2023 | ₹2.46 Cr | -31.13 | |
| Mar2022 | ₹3.58 Cr | -20.61 | |
| Mar2021 | ₹4.50 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,962.6 Cr | 13.2% | -10.1% | 20.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 13.2% |
-10.1% |
20.6% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses